Search

everythinglearnresearchcommunity

for

Search:↓

Both LNG-IUD and systemic progestins are effective for fertility-sparing treatment, but close monitoring is needed due to recurrence risk.

A new method accurately measures cell changes in breast cancer.

Scalp cooling reduces hair loss during chemotherapy but doesn't help hair regrow after.

Droplet-based microfluidics improves delivery of bioactive compounds in food using precise encapsulation and release.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

High DKK1 levels predict worse survival in head and neck cancer.

Cronkhite-Canada syndrome is rare, with high mortality and cancer risk, needing more research for treatment guidelines.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

A new AI model diagnoses hair and scalp disorders with 92% accuracy, better than previous models.

High chromogranin A levels are linked to obesity and inflammation in polycystic ovary syndrome.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

A new method accurately measures a drug in skin for cancer therapy research.

A new method accurately measures nine specific hormones in human blood.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

New guidelines and referral pathways for skin conditions aim to improve care and referrals in Pakistan.

HairLossMultinet accurately classifies hair damage with 98% accuracy but needs a more diverse dataset for broader use.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Provenge extends prostate cancer survival by about 4 months.

Some cancer treatments can cause permanent hair loss.

A high dietary antioxidant index may lower the risk of various diseases, but more research is needed.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

A rare ovarian cancer with a good outlook was found in a woman with unusual hair growth and abdominal symptoms.

Dermatologists found teledermatology useful and confidence-boosting for diagnosing skin conditions, but faced limitations like technical issues and prescription restrictions. Despite this, they saw its potential to improve access to skin care, especially in remote areas.

Nanotechnology shows promise for better drug delivery and cancer treatment.

Androgen lowering medications don't significantly change HCV-related liver cancer risk in men.

FDG PET/CT can improve cancer treatment plans in dogs.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Testicular microlithiasis may increase the risk of testicular cancer and patients with it should be closely monitored.